Barclays Maintains Overweight on Danaher, Raises Price Target to $255

Barclays analyst Luke Sergott has maintained an Overweight rating on Danaher (NYSE: DHR) and increased the price target from $230 to $255. This adjustment reflects a positive outlook on the company's performance.